Leveraging Network Target Theory for Efficient Prediction of Drug‐Disease Interactions: A Transfer Learning Approach
Advanced Science · 2025
DOI: 10.1002/advs.202409130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Qingyuan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin…. Hauptthemen laut MEDLINE: Drug Discovery, Deep Learning. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Key Medical Discipline(Specialty) Construction Project, Research Project Funding of Henan Academy of Sciences.
Abstract (Originalsprache)
Efficient virtual screening methods can expedite drug discovery and facilitate the development of innovative therapeutics. This study presents a novel transfer learning model based on network target theory, integrating deep learning techniques with diverse biological molecular networks to predict drug‐disease interactions. By incorporating network techniques that leverage vast existing knowledge, the approach enables the extraction of more precise and informative drug features, resulting in the identification of 88,161 drug‐disease interactions involving 7,940 drugs and 2,986 diseases. Furthermore, this model effectively addresses the challenge of balancing large‐scale positive and negative samples, leading to improved performance across various evaluation metrics such as an Area under curve (AUC) of 0.9298 and an F1 score of 0.6316. Moreover, the algorithm accurately predicts drug combinations and achieves an F1 score of 0.7746 after fine‐tuning. Additionally, it identifies two previously unexplored synergistic drug combinations for distinct cancer types in disease‐specific biological network environments. These findings are further validated through in vitro cytotoxicity assays, demonstrating the potential of the model to enhance drug development and identify effective treatment regimens for specific diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Can…
- Institute for TCM-X, Department of Automation, Tsinghua University, Beijing, 100084, China.
- Henan Academy of Sciences, Henan, 450046, China.
Förderung
- National Natural Science Foundation of China
- Tianjin Key Medical Discipline(Specialty) Construction Project
- Research Project Funding of Henan Academy of Sciences
Zitieren
APA
Liu, Q., Chen, Z., Wang, B., Pan, B., Zhang, Z., Shen, M., Zhao, W., Zhang, T., Li, S., & Liu, L. (2025). Leveraging Network Target Theory for Efficient Prediction of Drug‐Disease Interactions: A Transfer Learning Approach. Advanced Science. https://doi.org/10.1002/advs.202409130
Vancouver
Liu Q, Chen Z, Wang B, Pan B, Zhang Z, Shen M, et al. Leveraging Network Target Theory for Efficient Prediction of Drug‐Disease Interactions: A Transfer Learning Approach. Advanced Science. 2025. doi:10.1002/advs.202409130
BibTeX
@article{Liu2025,
author = {Liu, Qingyuan and Chen, Zizhen and Wang, Boyang and Pan, Boyu and Zhang, Zhuoyu and Shen, Miaomiao and Zhao, Weibo and Zhang, Tingyu and Li, Shao and Liu, Liren},
title = {Leveraging Network Target Theory for Efficient Prediction of Drug‐Disease Interactions: A Transfer Learning Approach},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409130}
}
EUVIMED